Dallas, TX -- (SBWire) -- 03/10/2011 -- With pharmaceutical companies increasingly looking for ways to extend the revenue-earning lifetime of their biggest products, drug delivery has become an important focus of the industry. Kalorama’s Drug Delivery Markets: Implantable / Injectable and Needle-Free Delivery Systems provides detail for business planners on the market for implantable / injectable delivery system markets.
Biopharmaceutical products are driving growth of needle-free systems; there will likely be significant increases in revenues in the vaccine arena. This report looks at that trend and reports current and forecasted revenues for the implantable/injectable drug delivery market, segmented into two main categories:
Needle-free drug delivery
Other Injectable/Implantable
Kalorama’s unique analysis offers segmentation of this market for:
Drug Delivery Techology Revenues
Pharmaceuticals Sold via Delivery Technology
This breakout makes the report relevant to business plans of either device technology companies or pharmaceutical concerns. (This market analysis does not include drug-eluding stents or prefilled or regular syringes. Kalorama considers these seperate markets)
With pharmaceutical companies increasingly turning to drug delivery to extend the revenue-earning lifetime of their biggest products, drug delivery has become an important focus of the pharmaceutical industry.
Kalorama’s Drug Delivery Markets: Implantable / Injectable and Needle-Free Delivery Systems, the second volume of Kalorama’s popular series focusing on global drug delivery systems markets, provides the definitive break down of the market for implantable / injectable delivery system markets. The report covers both pharmaceuticals sold through implantable/injectable delivery systems and the technologies themselves including:
This focused report provides information on the revenues for relevant companies and provides information critical to assessing the opportunities available in this market, including:
Detailed Profiles of Key Companies in Implantable/Injectable Delivery and Brief Round-Up of smaller players
Current Market Size and Forecasts to 2013
Needle-Free Cost Savings, Protein-Coated Microcrystal Technology, Nanotechnology, and Other Trends and Developments
New Products in Development
Kalorama’s trusted information-gathering process provides most accurate study of the implantable/injectable delivery drug market available today. Information and analysis presented in this report is based on extensive interviews with senior management of top companies in the industry. While major research literature and government information is culled, information is corroborated and key market insights originate from interviews with industry leaders.
Companies Profiled in the report include:
Alkermes, Inc.
ALZA Corp.
Antares Pharma, Inc.
Bioject Medical Technologies, Inc.
CyDex, Inc.
MGI Pharma, Inc
Nektar Therapeutics
Pacira Pharmaceuticals, Inc.
pSivida
SurModics, Inc
Zogenix Corporation
AP Pharma
Baxter BioPharma Solutions
QLT USA, Inc
Ypsomed Holding AG
Kalorama has also published Drug Delivery Markets: Oral Delivery, which details markets for oral technology enhancements which have increased drug product sales and extended patent life.
Buy Now: Market Research
Browse All: Drug Delivery Market
Drug Delivery Markets Implantable Injectable and Needle Free Delivery Systems
http://www.reportsnreports.com/reports/253-drug-delivery-markets-implantable-injectable-and-needle-free-del.html
Related Reports
Drug Delivery: Heading Towards A Needle Free Future
Global Injectable Drug Delivery Market (2010 – 2015)
Drug Delivery Devices Market Outlook in China to 2016 – Inhalation Systems, Infusion Systems and Others
Drug Delivery Markets Oral Delivery
Innovations in Oral Solid Drug Delivery: Advances in nanotechnology, controlled formulations & peptide delivery
Aveva Drug Delivery Systems-Detailed Product Pipeline
3M Drug Delivery Systems (a division of 3M Company NYSE : MMM)-Deals & Alliances Report
Advances in the Transdermal Drug Delivery Market: Market size, leading players, therapeutic focus and innovative technologies
The Future of Software Delivery: The opportunities and challenges of emerging software delivery models
Advanced Drug Delivery Markets (Liposomes, Polymers and Monoclonal Antibodies)
About ReportsnReports
ReportsnReports houses a comprehensive online library of more than 50,000 reports, in-depth market research studies of 5000+ micro markets, and 25 industry specific websites. The reports are analytically and statistically rich, and offer a comprehensive view of the dynamic market scenario across the globe. Our client list boasts of many eminent publishers of such reports from across the world. As a third-party reseller of market research reports, we employ various marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques, in order to generate better revenues for our clients, entailing positive and robust results.
Contact:
Ms. Sunita
7557 Rambler road,
Suite 727, Dallas, TX 75231
Tel: +1-888-989-8004
Website:http://www.reportsnreports.com
http://reportsnreports.wordpress.com/
Drug Delivery Markets Implantable Injectable and Needle Free Delivery Systems